12
Sep
Shares of Granules India tumbled over 16 per cent during intraday trading on Thursday, September 12, after the company announced that the inspection of its Gagillapur FD facility by the USFDA, conducted from August 26 to September 6, 2024, concluded with six observations.In response, the company issued a statement to reassure concerned investors, underscore its commitment to resolve the issues raised. "We acknowledge that many investors have sought clarifications, and we would like to assure them that we are actively addressing the comments and remain fully committed to resolving the issues raised," Granules India said in its stock exchange filing.The…